scholarly journals PIN69 A PATIENT SATISFACTION QUESTIONNAIRE FOR ASSESSING PHARMACEUTICAL CARE SERVICES IN NIGERIAN HIV CLINICS

2009 ◽  
Vol 12 (7) ◽  
pp. A430
Author(s):  
NA Njilele ◽  
OI Ekwunife ◽  
CV Ukwe
2018 ◽  
Vol 31 (8) ◽  
pp. 988-999 ◽  
Author(s):  
Mahdi Nouri ◽  
Saeideh Ghaffarifar ◽  
Homayoun Sadeghi-Bazargani

Purpose The purpose of this paper is to explore the validity and reliability of the Persian version of the patient satisfaction questionnaire (PVPSQ). The study addressed the communication skills section of the PSQ specifically. Design/methodology/approach This cross-sectional study was conducted in 2015 to determine the validity and reliability of the Persian version of the patient satisfaction questionnaire (PSQ). In total, 538 patients (ten in pilot, 488 in tests, 40 in retest), 14 experts and 198 residents participated. The items’ impact score, content validity index, and content validity ratio were calculated. Construct validity and reliability of the scale were examined with exploratory factor analysis, Cronbach’s α, and the Intraclass correlation coefficient (ICC), respectively. Findings The questionnaire demonstrated a content validity index=0.94, content validity ratio=0.84, impact score=4.61, Cronbach’s α=0.93 and ICC=0.513 (p<0.00). A single factor was found in the eigenvalue distribution of the PSQ that predicted approximately 93 percent of the variance. Practical implications The results of this study will permit researchers in all Persian-speaking countries to use a valid and reliable Persian version of the PSQ to evaluate patients’ satisfaction with residents’ communication skills. Originality/value There were a few Persian questionnaires to assess patient satisfaction with physicians’ communication skills, but their psychometric properties had not been reported until the time of this study. By using the PVPSQ, both researchers at Iranian universities of medical sciences and researchers in other Persian-speaking countries can assess residents’ communication skills from the patient’s perspective more reliably.


2013 ◽  
Author(s):  
Cecile M. A. Utens ◽  
Lucas M. A. Goossens ◽  
Onno C. P. van Schayck ◽  
Maureen P. M. H. Rutten-van Mölken ◽  
Walter van Litsenburg ◽  
...  

2010 ◽  
Author(s):  
Pauline S. M. Lai ◽  
S. S. Chua ◽  
S. P. Chan ◽  
W. Y. Low ◽  
Ian C. K. Wong

2019 ◽  
Vol 45 (8) ◽  
pp. 1213
Author(s):  
Stine E. Nielsen ◽  
Anne M. Eriksen ◽  
Anders R. Ivarsen ◽  
Henrik Sejersen ◽  
Christina Mφller ◽  
...  

2017 ◽  
Vol 18 (3) ◽  
pp. 180-185 ◽  
Author(s):  
Sandeep G. Mistry ◽  
Simon Carr ◽  
Jane Martin ◽  
David R. Strachan ◽  
Christopher H. Raine ◽  
...  

1997 ◽  
Vol 31 (6) ◽  
pp. 713-719 ◽  
Author(s):  
Michelle CH Shibley ◽  
Carol B Pugh

OBJECTIVE: To implement and evaluate pharmaceutical care services for patients with hyperlipidemias in the community pharmacy setting, to evaluate the results of a pharmaceutical care training process for pharmacists by using an assessment quiz, and to measure patient outcomes resulting from provision of pharmaceutical care to patients with hyperlipidemia. DESIGN: A prospective study was conducted over a 1 -year period. Patients served as their own controls. SETTING: Two independent community pharmacies in Richmond, Virginia. PARTICIPANTS: Twenty-five adult patients with confirmed dyslipidemias completed the study. INTERVENTIONS: Study pharmacists assessed each patient and assisted in setting therapeutic goals; patients also completed a visit with a registered dietitian. Drug therapy recommendations were made to physicians by the pharmacist when appropriate. Follow-up was scheduled with the pharmacist to ensure positive outcomes and reduce adverse effects. MAIN OUTCOME MEASURES: Fasting lipoprotein profiles were measured initially and at 6 and 12 months. The SF-36 survey, the MacKeigan-Larson satisfaction survey, and a patient opinion survey were administered initially and at the conclusion of the study. RESULTS: Total cholesterol and low-density lipoprotein cholesterol values were significantly decreased at 12 months compared with either the baseline or 6-month values (p < 0.02). Significant improvement was found in several domains of the surveys; quality of life, patient satisfaction with pharmacy services, and patient opinions on the role of the pharmacist improved after the intervention. CONCLUSIONS: Pharmaceutical care may positively affect lipid values, quality of life, and patient satisfaction.


Sign in / Sign up

Export Citation Format

Share Document